Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Patient Centered Approach to Disease Modification in Scleroderma: Results from the faSScinate Trial of Tocilizumab Compared to Placebo in Active Diffuse Cutaneous Systemic Sclerosis Arnold, M., Khanna, D., Denton, C., Lin, C., van Laar, J., Frech, T., Anderson, M., Baron, M., Chung, L., Fierlbeck, G., Allanore, Y., Riemekasten, G., Steen, V., Mueller-Ladner, U., Spotswood, H., Burke, L., Siegel, J., Jahreis, A., Furst, D., Pope, J. J RHEUMATOL PUBL CO. 2017: 881
View details for Web of Science ID 000404641800094